Foundation for the Accreditation of Cellular Therapy (FACT) Accreditation
The Fox Chase-Temple Bone Marrow Transplant Program is fully accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) and a participating provider in the National Marrow Donor Program (NMDP). In 2020, our BMT program was reaccredited for adult allogeneic and autologous hematopoietic progenitor cell transplantation, peripheral blood cellular therapy product collection, and cellular therapy product processing with minimal manipulation. Also included was a new accreditation for immune effector cells.
Center for International Blood and Marrow Transplant Research Recognition
The Fox Chase - Temple University Hospital BMT Program has been recognized by the Center for International Blood and Marrow Transplant Research (CIBMTR) for having a one-year transplant survival rate of "above expected" when compared to the average transplant center in the United States. Our program is one of only 17 centers (out of 172 centers) that were recognized as “over performing” in CIBMTR’s risk-adjusted analysis of expected vs. actual one-year survival statistics. We are the only transplant center in the tri-state area (PA-NJ-DE) that achieved this recognition in 2020.
Blue Cross Blue Shield Blue Distinction, Transplant – Bone Marrow/Stem Cell
Temple University Hospital earned “Blue Distinction Transplant – Bone Marrow/Stem Cell” from Blue Cross Blue Shield in recognition of the Fox Chase-Temple University Hospital Bone Marrow Transplant (BMT) Program’s expertise in performing adult bone marrow transplants.
Blue Distinction Centers (BDC) met overall quality measures developed with input from the medical community. A Local Blue Plan may require additional criteria for providers located in its own service area; for details, contact your Local Blue Plan. Blue Distinction Centers+ (BDC+) also met cost measures that address consumers’ need for affordable healthcare. Each provider’s cost of care is evaluated using data from its Local Blue Plan. Providers in CA, ID, NY, PA, and WA may lie in two Local Blue Plans’ areas, resulting in two evaluations for cost of care, and their own Local Blue Plans decide whether one or both cost of care evaluation(s) must meet BDC+ national criteria. National criteria for BDC and BDC+ are displayed on www.bcbs.com. Individual outcomes may vary. For details on a provider’s in-network status or your own policy’s coverage, contact your Local Blue Plan and ask your provider before making an appointment. Neither Blue Cross and Blue Shield Association nor any Blue Plans are responsible for non-covered charges or other losses or damages resulting from Blue Distinction or other provider finder information or care received from Blue Distinction or other providers.